Literature DB >> 28833074

Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.

Elizabeth M Cespedes Feliciano1, Ross L Prentice2, Aaron K Aragaki2, Marian L Neuhouser2, Hailey R Banack3, Candyce H Kroenke1, Gloria Y F Ho4, Oleg Zaslavsky5, Howard D Strickler6, Ting-Yuan David Cheng7, Rowan T Chlebowski8, Nazmus Saquib9, Rami Nassir10, Garnet Anderson2, Bette J Caan1.   

Abstract

Often, studies modeling an exposure's influence on time to disease-specific death from study enrollment are incorrectly interpreted as if based on time to death from disease diagnosis. We studied 151,996 postmenopausal women without breast or colorectal cancer in the Women's Health Initiative with weight and height measured at enrollment (1993-1998). Using Cox regression models, we contrast hazard ratios (HR) from two time-scales and corresponding study subpopulations: time to cancer death after enrollment among all women and time to cancer death after diagnosis among only cancer survivors. Median follow-up from enrollment to diagnosis/censoring was 13 years for both breast (7,633 cases) and colorectal cancer (2,290 cases). Median follow-up from diagnosis to death/censoring was 7 years for breast and 5 years for colorectal cancer. In analyses of time from enrollment to death, body mass index (BMI) ≥ 35 kg/m2 versus 18.5-<25 kg/m2 was associated with higher rates of cancer mortality: HR = 1.99; 95% CI: 1.54, 2.56 for breast cancer (p trend <0.001) and HR = 1.40; 95% CI: 1.04, 1.88 for colorectal cancer (p trend = 0.05). However, in analyses of time from diagnosis to cancer death, trends indicated no significant association (for BMI ≥ 35 kg/m2 , HR = 1.25; 95% CI: 0.94, 1.67 for breast [p trend = 0.33] and HR = 1.18; 95% CI: 0.84, 1.86 for colorectal cancer [p trend = 0.39]). We conclude that a risk factor that increases disease incidence will increase disease-specific mortality. Yet, its influence on postdiagnosis survival can vary, and requires consideration of additional design and analysis issues such as selection bias. Quantitative tools allow joint modeling to compare an exposure's influence on time from enrollment to disease incidence and time from diagnosis to death.
© 2017 UICC.

Entities:  

Keywords:  breast cancer; colorectal cancer; methods; mortality; obesity; survival

Mesh:

Year:  2017        PMID: 28833074      PMCID: PMC5761345          DOI: 10.1002/ijc.30931

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

Review 2.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

3.  Re: Collider Bias Is Only a Partial Explanation for the Obesity Paradox.

Authors:  Vivian Viallon; Marine Dufournet
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

Review 4.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis.

Authors:  Melinda Protani; Michael Coory; Jennifer H Martin
Journal:  Breast Cancer Res Treat       Date:  2010-06-23       Impact factor: 4.872

5.  Recreational physical activity, body mass index, and survival in women with colorectal cancer.

Authors:  Josephina G Kuiper; Amanda I Phipps; Marian L Neuhouser; Rowan T Chlebowski; Cynthia A Thomson; Melinda L Irwin; Dorothy S Lane; Jean Wactawski-Wende; Lifang Hou; Rebecca D Jackson; Ellen Kampman; Polly A Newcomb
Journal:  Cancer Causes Control       Date:  2012-10-02       Impact factor: 2.506

Review 6.  Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities.

Authors:  Sao Jiralerspong; Pamela J Goodwin
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

7.  Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity.

Authors:  Christie Eheman; S Jane Henley; Rachel Ballard-Barbash; Eric J Jacobs; Maria J Schymura; Anne-Michelle Noone; Liping Pan; Robert N Anderson; Janet E Fulton; Betsy A Kohler; Ahmedin Jemal; Elizabeth Ward; Marcus Plescia; Lynn A G Ries; Brenda K Edwards
Journal:  Cancer       Date:  2012-03-28       Impact factor: 6.860

8.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

9.  Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.

Authors:  Candyce H Kroenke; Romain Neugebauer; Jeffrey Meyerhardt; Carla M Prado; Erin Weltzien; Marilyn L Kwan; Jingjie Xiao; Bette J Caan
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

10.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

View more
  8 in total

1.  Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Authors:  Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Michael S Simon; JoAnn E Manson; Marian L Neuhouser; Kathy Pan; Marcia L Stefanic; Thomas E Rohan; Dorothy Lane; Lihong Qi; Linda Snetselaar; Ross L Prentice
Journal:  JAMA Oncol       Date:  2018-10-11       Impact factor: 31.777

2.  Obesity and Cancer Risk in White and Black Adults: A Prospective Cohort Study.

Authors:  Justin C Brown; Shengping Yang; Emily F Mire; Xiaocheng Wu; Lucio Miele; Augusto Ochoa; Jovanny Zabaleta; Peter T Katzmarzyk
Journal:  Obesity (Silver Spring)       Date:  2021-06       Impact factor: 9.298

3.  Obesity and cancer death in white and black adults: A prospective cohort study.

Authors:  Justin C Brown; Shengping Yang; Emily F Mire; Xiaocheng Wu; Lucio Miele; Augusto Ochoa; Jovanny Zabaleta; Peter T Katzmarzyk
Journal:  Obesity (Silver Spring)       Date:  2021-10-24       Impact factor: 9.298

4.  The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers.

Authors:  Justin C Brown; Elizabeth M Cespedes Feliciano; Bette J Caan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-13       Impact factor: 12.910

5.  Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial.

Authors:  Rowan T Chlebowski; Steve Rapp; Aaron K Aragaki; Kathy Pan; Marian L Neuhouser; Linda G Snetselaar; JoAnn E Manson; Jean Wactawski-Wende; Karen C Johnson; Kathleen Hayden; Laura D Baker; Victor W Henderson; Lorena Garcia; Lihong Qi; Ross L Prentice
Journal:  EClinicalMedicine       Date:  2020-01-08

6.  Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.

Authors:  Stanley Teleka; Sylvia H J Jochems; Christel Häggström; Angela M Wood; Bengt Järvholm; Marju Orho-Melander; Fredrik Liedberg; Tanja Stocks
Journal:  Cancer Med       Date:  2021-01-16       Impact factor: 4.452

7.  Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis.

Authors:  Christine M Friedenreich; Chelsea R Stone; Winson Y Cheung; Sandra C Hayes
Journal:  JNCI Cancer Spectr       Date:  2019-10-17

8.  Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk.

Authors:  Rebecca D Kehm; Robert J MacInnis; Esther M John; Yuyan Liao; Allison W Kurian; Jeanine M Genkinger; Julia A Knight; Sarah V Colonna; Wendy K Chung; Roger Milne; Nur Zeinomar; Gillian S Dite; Melissa C Southey; Graham G Giles; Sue-Anne McLachlan; Kristen D Whitaker; Michael L Friedlander; Prue C Weideman; Gord Glendon; Stephanie Nesci; Kelly-Anne Phillips; Irene L Andrulis; Saundra S Buys; Mary B Daly; John L Hopper; Mary Beth Terry
Journal:  JNCI Cancer Spectr       Date:  2021-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.